Literature DB >> 34420874

Enhancers in disease: molecular basis and emerging treatment strategies.

Annique Claringbould1, Judith B Zaugg2.   

Abstract

Enhancers are genomic sequences that play a key role in regulating tissue-specific gene expression levels. An increasing number of diseases are linked to impaired enhancer function through chromosomal rearrangement, genetic variation within enhancers, or epigenetic modulation. Here, we review how these enhancer disruptions have recently been implicated in congenital disorders, cancers, and common complex diseases and address the implications for diagnosis and treatment. Although further fundamental research into enhancer function, target genes, and context is required, enhancer-targeting drugs and gene editing approaches show great therapeutic promise for a range of diseases.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  BET inhibition; chromatin organization; complex disease; enhancer; enhanceropathy; epigenetic drugs; gene regulation; genome-wide association studies; structural variation

Mesh:

Year:  2021        PMID: 34420874     DOI: 10.1016/j.molmed.2021.07.012

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  8 in total

Review 1.  Enhancer-gene specificity in development and disease.

Authors:  Tomás Pachano; Endika Haro; Alvaro Rada-Iglesias
Journal:  Development       Date:  2022-06-10       Impact factor: 6.862

2.  Multiscale 3D genome organization underlies ILC2 ontogenesis and allergic airway inflammation.

Authors:  Michaël F Michieletto; John J Tello-Cajiao; Walter K Mowel; Aditi Chandra; Sora Yoon; Leonel Joannas; Megan L Clark; Monica T Jimenez; Jasmine M Wright; Patrick Lundgren; Adam Williams; Christoph A Thaiss; Golnaz Vahedi; Jorge Henao-Mejia
Journal:  Nat Immunol       Date:  2022-09-01       Impact factor: 31.250

3.  3D Chromatin Organization Involving MEIS1 Factor in the cis-Regulatory Landscape of GJB2.

Authors:  Anaïs Le Nabec; Clara Blotas; Alinéor Briset; Mégane Collobert; Claude Férec; Stéphanie Moisan
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

4.  Analysis of the landscape of human enhancer sequences in biological databases.

Authors:  Juan Mulero Hernández; Jesualdo Tomás Fernández-Breis
Journal:  Comput Struct Biotechnol J       Date:  2022-05-30       Impact factor: 6.155

Review 5.  Context-dependant enhancers as a reservoir of functional polymorphisms and epigenetic markers linked to alcohol use disorders and comorbidities.

Authors:  Alasdair MacKenzie; Elizabeth A Hay; Andrew R McEwan
Journal:  Addict Neurosci       Date:  2022-06

6.  Toward transcriptomics as a primary tool for rare disease investigation.

Authors:  Stephen B Montgomery; Jonathan A Bernstein; Matthew T Wheeler
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24

7.  Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer.

Authors:  Michael W Lewis; Kamila Wisniewska; Caitlin M King; Shen Li; Alisha Coffey; Michael R Kelly; Matthew J Regner; Hector L Franco
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.575

Review 8.  Epigenetics of alcohol-related liver diseases.

Authors:  Nawras W Habash; Tejasav S Sehrawat; Vijay H Shah; Sheng Cao
Journal:  JHEP Rep       Date:  2022-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.